Are mRNA vaccines safe and effective? What to know as RFK Jr. halts funding
Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in funding for the development of mRNA vaccines. The 22 projects are managed by the Biomedical Advanced Research and Development Authority (BARDA).
'The data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu,' Kennedy, a longtime vaccine critic, said in a statement. 'We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.'
4 Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in funding for the development of mRNA vaccines.
AP
Several studies have demonstrated that mRNA COVID-19 vaccines were over 90% effective at preventing severe illness and death.
Vaccine researchers immediately took issue with the fiscal gutting, calling it a major setback for science.
'I don't think I've seen a more dangerous decision in public health in my 50 years in the business,' said Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations.
Here's a closer look at how mRNA vaccines work.
What is mRNA?
All living cells have ribonucleic acid, an essential biological molecule known as RNA.
RNA's primary role in the body is to make proteins, which are needed for virtually every cellular process, from building and repairing tissues to defending the body from bacteria and viruses and transporting nutrients and oxygen.
4 The COVID-19 vaccine manufactured by Pfizer and Biontec is administered during a clinical trial.
EPA/Biontech SE/Handout
Proteins are synthesized using three main types of RNA — messenger RNA (mRNA), transfer RNA (tRNA) and ribosomal RNA (rRNA).
MRNA's job is to carry information for protein making from DNA to the cell's ribosomes, where it's translated into proteins.
How do mRNA vaccines work?
MRNA can be created in a laboratory and injected into the body to instruct cells to make a protein associated with a specific virus.
The body recognizes the protein as foreign and produces antibodies to combat it. When the actual virus or pathogen invades the body, the immune system is ready to neutralize it, preventing or reducing the severity of illness.
Though mRNA was discovered in the early 1960s, the first mRNA vaccine wasn't approved for human use until 2020.
4 German firm BioNTech, Pfizer's partner on its Covid vaccine, is developing mRNA-based vaccines for cancers at a rapid pace.
Photothek via Getty Images
The US Food and Drug Administration (FDA) authorized Pfizer's COVID-19 vaccine for emergency use in December 2020 and later granted full approval.
The vaccine uses mRNA to tell cells to make a harmless piece of the coronavirus's spike protein.
Moderna's COVID-19 vaccine was also granted full approval by the FDA.
MRNA vaccines are being explored for the treatment of cancer, food allergies and infectious diseases.
Researchers say that mRNA vaccines can be developed faster than traditional vaccines because they do not require the time-consuming process of growing live virus cultures in a lab.
'The theoretical advantage of mRNA-based vaccines lies in their rapid adaptability,' Grant Hansman, senior research fellow at the Institute for Biomedicine and Glycomics at Griffith University in Australia, wrote this week in The Conversation.
'They will potentially allow annual updates to match circulating strains.'
4 University College London Hospital (UCLH) in London is testing novel cancer immunotherapy that aims to prevent skin cancer from recurring. The mRNA-based technology is for people who have already had high-risk melanomas removed.
PA Images via Getty Images
The Centers for Disease Control and Prevention notes that mRNA vaccines do not contain any live viruses or pathogens and do not alter a person's DNA.
The mRNA molecule eventually breaks down in the body.
The Cleveland Clinic reports that the risks of mRNA vaccines include pain or swelling at the injection site, fever, fatigue, headaches, muscle aches and allergic reactions.
In his statement, Kennedy said that mRNA vaccines will be phased out in favor of whole killed virus vaccines, a traditional approach that uses entire pathogens that have been inactivated through heat, radiation or chemicals.
Though it's a tried-and-true method of immunization, critics have raised concerns that these vaccines produce a weaker immune response than mRNA vaccines and pose manufacturing and logistical challenges.
With Post wires
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
10 minutes ago
- Politico
China fights mosquito-borne chikungunya virus with drones, fines and nets
'What makes this event notable is that chikungunya has never been established in mainland China before,' Lopez-Camacho said in a statement. 'This suggests that most of the population had no preexisting immunity, making it easier for the virus to spread quickly.' Chinese state television has shown workers spraying insecticide around city streets, residential areas, construction sites and other areas where people may come into contact with mosquitoes. Workers sprayed some places before entering office buildings. Unusually heavy rains and high temperatures have worsened the crisis in China, and authorities are using drones to try to find standing water, where mosquitoes lay eggs. Authorities also have threatened to fine people who don't empty water from outdoor receptacles. Residents can be subject to fines of up to 10,000 yuan ($1,400) and have their electricity cut off. Because of the virus, the U.S. has issued a travel advisory suggesting that Americans take extra precautions when visiting China's Guangdong province, where Foshan is located, as well as Bolivia and some island nations in the Indian Ocean. Since the 2003 SARS outbreak, China has used strict measures to fight the spread of viruses, including hard-line tactics during the Covid-19 pandemic. This time, patients are being forced to stay in hospital in Foshan for at least one week and authorities briefly enforced a two-week home quarantine, which was dropped because the disease cannot be transmitted between people. Reports also have emerged of attempts to stop the spread of chikungunya with fish that eat mosquito larvae and even larger mosquitoes to eat the insects carrying the virus. Officials have held meetings and adopted protocols at the national level in a sign of China's determination to eliminate the outbreak and avoid public and international criticism.
Yahoo
an hour ago
- Yahoo
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test
Becton, Dickinson and Company (NYSE:BDX) is one of the . On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S. FDA for a new, at-home HPV test. The new HPV test focuses on patients to self-collect a sample at their home using a swab, the size of a Q-tip, simplifying lab processing. According to BD, this method also reports more high-risk strains of HPV compared to other tests on the market today. A person wearing a state-of-the-art medical device for nerve conduction tests. 'We envision a world where women are empowered with access and a choice for their HPV screening, whether it be in a routine visit at the doctor's office or the comfort and privacy of their own home via a self-collected sample. Cervical cancer and the loss of more than 4,000 women per year to this devastating disease is preventable, and we believe at-home testing is an important leap forward to our goal of eliminating this type of cancer,' said Nikos Pavlidis, president of BD Diagnostic Solutions. BD's new HPV test will include a state-of-the-art self-collection swab technology that also offers convenient mailing from home to the lab, supporting broader participation in cervical cancer screening programs. The self-collected swab requires no manual sample preparation by clinical laboratory technologists. This process will allow them to focus on higher-value work. Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that focuses on the development, manufacturing, and sale of various medical supplies, devices, diagnostic products, and laboratory equipment. While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Newsweek
an hour ago
- Newsweek
Ice Cream Recall Map Shows States With New Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. DFA Dairy Brands, LLC, is recalling the Friendly's brand of Cookies & Cream ice cream due to undeclared soy and wheat concerns. Newsweek reached out to the company via email on Wednesday for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. People with a wheat or soy allergy could experience a "serious or life-threatening allergic reaction if they consume these products," the FDA warns. What To Know In the alert, the FDA says that the recalled products were packaged mistakenly in Friendly's Vanilla Bean cartons with a Cookies & Cream lid. The recalled products were distributed through UNFI to retail locations in Pennsylvania, Maryland and Virginia. Below is a map showing the states impacted by the recall: The ice cream was sold in 48-fluid ounce containers with a best-by date of November 26, 2025. No other Friendly's products are impacted by the recall, the FDA alert notes. What People Are Saying The FDA in the alert, in part: "The voluntary recall was initiated after it was discovered that a limited quantity of Cookies & Cream ice cream was mistakenly packaged in Friendly's Vanilla Bean ice cream cartons that did not identify the soy and wheat ingredients. No illnesses or adverse reactions have been reported. This recall is being made with the knowledge of the U.S. Food and Drug Administration." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall; the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall. "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled product are urged to return the ice cream to the original place of purchase for a refund, the FDA alert notes. People with additional questions may contact DFA Dairy Brands, LLC, via phone at 800- 587-2259. Further recalls or updates are possible as investigations continue, and consumers are encouraged to monitor FDA alerts for developments.
